1. Home
  2. COOP vs RGEN Comparison

COOP vs RGEN Comparison

Compare COOP & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COOP
  • RGEN
  • Stock Information
  • Founded
  • COOP 1994
  • RGEN 1981
  • Country
  • COOP United States
  • RGEN United States
  • Employees
  • COOP N/A
  • RGEN N/A
  • Industry
  • COOP Finance: Consumer Services
  • RGEN Medical/Dental Instruments
  • Sector
  • COOP Finance
  • RGEN Health Care
  • Exchange
  • COOP Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • COOP 8.2B
  • RGEN 8.0B
  • IPO Year
  • COOP N/A
  • RGEN N/A
  • Fundamental
  • Price
  • COOP $149.12
  • RGEN $118.85
  • Analyst Decision
  • COOP Buy
  • RGEN Buy
  • Analyst Count
  • COOP 8
  • RGEN 11
  • Target Price
  • COOP $130.14
  • RGEN $172.67
  • AVG Volume (30 Days)
  • COOP 915.2K
  • RGEN 736.8K
  • Earning Date
  • COOP 07-24-2025
  • RGEN 07-29-2025
  • Dividend Yield
  • COOP N/A
  • RGEN N/A
  • EPS Growth
  • COOP N/A
  • RGEN N/A
  • EPS
  • COOP 8.81
  • RGEN N/A
  • Revenue
  • COOP $2,221,000,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • COOP $19.78
  • RGEN $13.93
  • Revenue Next Year
  • COOP $11.71
  • RGEN $14.35
  • P/E Ratio
  • COOP $16.40
  • RGEN N/A
  • Revenue Growth
  • COOP 9.52
  • RGEN 4.88
  • 52 Week Low
  • COOP $78.20
  • RGEN $102.97
  • 52 Week High
  • COOP $151.48
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • COOP 68.12
  • RGEN 39.78
  • Support Level
  • COOP $138.83
  • RGEN $120.68
  • Resistance Level
  • COOP $147.23
  • RGEN $135.30
  • Average True Range (ATR)
  • COOP 6.11
  • RGEN 4.93
  • MACD
  • COOP 0.86
  • RGEN -0.64
  • Stochastic Oscillator
  • COOP 91.32
  • RGEN 18.40

About COOP Mr. Cooper Group Inc.

Mr. Cooper Group Inc is a home loan servicer. The company focuses on delivering a variety of servicing and lending products. It has operating segments namely Servicing segment which performs operational activities on behalf of investors or owners of the underlying mortgages and mortgage servicing rights, including collecting and disbursing borrower payments, investor reporting, and customer service, The Originations segment originates residential mortgage loans through a direct-to-consumer channel, which provides refinance options for existing customers, and through a correspondent channel, which purchases or originates loans from mortgage bankers and brokers, and the Corporate segment. The Servicing segment of the company generates maximum revenue.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: